SLC04A1, SLC22A2 and SLC28A2 variants not related to methotrexate efficacy or toxicity in rheumatoid arthritis patients

Author(s):
Eektimmerman, F.; Swen, J.J.; Bohringer, S.; Aslibekyan, S.; Allaart, C.F.; Guchelaar, H.J. (0000-0002-7085-1383)
Published
2018
Publication type
Article / Letter to editor
methotrexatepharmacogeneticsrheumatoid arthritisSLCsolute carrier
Date issued
2018-05-31
Language
English
Is part of
Pharmacogenomics (2018), Vol. 19, no. 7, p. 613-619
hdl
1887/95460
doi
10.2217/pgs-2018-0021